Key Financial Data Of Group

BrightPath Biotherapeutics Co., Ltd. - Filing #7580409

Concept	As at 2018-03-31	As at 2018-03-31	2017-04-01 to 2018-03-31	2017-04-01 to 2018-03-31	2016-04-01 to 2017-03-31	As at 2017-03-31	As at 2017-03-31	2016-04-01 to 2017-03-31	As at 2016-03-31	2015-04-01 to 2016-03-31	As at 2016-03-31	2015-04-01 to 2016-03-31	2014-04-01 to 2015-03-31	2014-04-01 to 2015-03-31	As at 2015-03-31	As at 2015-03-31	2013-04-01 to 2014-03-31	As at 2014-03-31	2013-04-01 to 2014-03-31	As at 2014-03-31
Key financial data of group
Business results of group
Net sales	—	—	354,410,000 JPY	354,410,000 JPY	529,612,000 JPY	—	—	529,612,000 JPY	—	822,556,000 JPY	—	JPY	821,625,000 JPY	JPY	—	—	933,388,000 JPY	—	JPY	—
Ordinary profit (loss)	—	—	-1,569,648,000 JPY	-1,573,292,000 JPY	-1,089,724,000 JPY	—	—	-1,116,556,000 JPY	—	-992,977,000 JPY	—	JPY	-413,501,000 JPY	JPY	—	—	19,144,000 JPY	—	JPY	—
Profit (loss) attributable to owners of parent	—	—	—	-1,577,142,000 JPY	—	—	—	-1,113,661,000 JPY	—	—	—	JPY	—	JPY	—	—	—	—	JPY	—
Comprehensive income	—	—	—	-1,578,417,000 JPY	—	—	—	-1,122,000,000 JPY	—	—	—	JPY	—	JPY	—	—	—	—	JPY	—
Net assets	6,950,570,000 JPY	6,950,570,000 JPY	—	—	—	5,201,149,000 JPY	5,199,874,000 JPY	—	2,720,663,000 JPY	—	JPY	—	—	—	1,024,127,000 JPY	JPY	—	JPY	—	189,323,000 JPY
Total assets	7,237,434,000 JPY	7,235,902,000 JPY	—	—	—	5,408,300,000 JPY	5,404,266,000 JPY	—	2,877,251,000 JPY	—	JPY	—	—	—	1,227,465,000 JPY	JPY	—	JPY	—	396,510,000 JPY
Net assets per share	164.78	164.78	—	—	—	139.17	139.17	—	85.53	—		—	—	—	30.74		—		—	4.53
Basic earnings (loss) per share	—	—	-41.25	-41.25	-32.74	—	—	-32.74	—	-35.28	—		-20.60		—	—	1.46	—		—
Diluted earnings per share	—	—				—	—		—		—				—	—		—		—
Equity-to-asset ratio	0.952 xbrli:pure	0.953 xbrli:pure	—	—	—	0.958 xbrli:pure	0.958 xbrli:pure	—	0.946 xbrli:pure	—	xbrli:pure	—	—	—	0.834 xbrli:pure	xbrli:pure	—	xbrli:pure	—	0.465 xbrli:pure
Rate of return on equity	—	—	xbrli:pure	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	xbrli:pure	xbrli:pure	—	—	0.100 xbrli:pure	—	xbrli:pure	—
Price-earnings ratio	—	—	xbrli:pure	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure	—	xbrli:pure	xbrli:pure	xbrli:pure	—	—	xbrli:pure	—	xbrli:pure	—
Net cash provided by (used in) operating activities	—	—	JPY	-1,591,336,000 JPY	JPY	—	—	-1,067,512,000 JPY	—	-908,711,000 JPY	—	JPY	-447,197,000 JPY	JPY	—	—	37,487,000 JPY	—	JPY	—
Net cash provided by (used in) investing activities	—	—	JPY	-111,556,000 JPY	JPY	—	—	-96,564,000 JPY	—	-32,125,000 JPY	—	JPY	-66,854,000 JPY	JPY	—	—	-3,688,000 JPY	—	JPY	—
Net cash provided by (used in) financing activities	—	—	JPY	3,281,082,000 JPY	JPY	—	—	3,559,188,000 JPY	—	2,672,558,000 JPY	—	JPY	1,247,716,000 JPY	JPY	—	—	JPY	—	JPY	—
Cash and cash equivalents	JPY	6,528,759,000 JPY	—	—	—	4,950,570,000 JPY	JPY	—	2,555,458,000 JPY	—	JPY	—	—	—	823,737,000 JPY	JPY	—	JPY	—	90,073,000 JPY
Number of employees	42 xbrli:pure	42 xbrli:pure	—	—	—	37 xbrli:pure	37 xbrli:pure	—	21 xbrli:pure	—	xbrli:pure	—	—	—	19 xbrli:pure	xbrli:pure	—	xbrli:pure	—	16 xbrli:pure
Average number of temporary employees	4 xbrli:pure	4 xbrli:pure	—	—	—	4 xbrli:pure	4 xbrli:pure	—	5 xbrli:pure	—	xbrli:pure	—	—	—	4 xbrli:pure	xbrli:pure	—	xbrli:pure	—	1 xbrli:pure